Playback speed
10 seconds
ESMO 2023 Insights: "REGOMA-OS Study Analyzing Regorafenib Efficacy & Safety in Recurrent Glioblastoma Patients"
By
Insights from 2023 ESMO Annual Meeting
FEATURING
Giuseppe Lombardi
By
Insights from 2023 ESMO Annual Meeting
FEATURING
Giuseppe Lombardi
0 views
November 17, 2023
Comments 0
Login to view comments.
Click here to Login